Tandem Diabetes Care, Inc. (LON:0M0F)

Market Cap	744.01M
Revenue (ttm)	731.15M
Net Income (ttm)	-149.96M
Shares Out	n/a
EPS (ttm)	-2.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	236
Average Volume	1,559
Open	14.82
Previous Close	15.38
Day's Range	13.71 - 14.82
52-Week Range	10.03 - 39.04
Beta	n/a
RSI	61.50
Earnings Date	Nov 6, 2025

About Tandem Diabetes Care

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company’s flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body. In addition, the company offers Tandem Device Updater used to update the pump software fr...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2006
• Employees: 2,650
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0M0F

Financial Performance

In 2024, Tandem Diabetes Care's revenue was $940.20 million, an increase of 25.74% compared to the previous year's $747.72 million. Losses were -$96.03 million, -56.86% less than in 2023.

Financial numbers in USD